Insecticides India Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/q3345g0lh33mp3rc23ej60la.pdf

Key Takeaways


Kaeros: The Two-Brand Strategy

Rajesh Aggarwal: "IIL is a popular name. IIL has got collaborations, the international collaboration, the products are first coming to IIL. IIL has got its own R&D center. So, the products are first coming to IIL. And Kaeros is a following company."

Demand & Season Outlook

Rajesh Aggarwal: "If there is a pull from the market, if there is a demand, if the farmer is coming to buy that product, then only he will get the product. Otherwise, there is a chance that even if a farmer comes to a shop, then he gets the alternate product."

Pricing & Raw Material Pressure


R&D, Partnerships & New Products

Rajesh Aggarwal: "After conducting so many trials, they give me about 10, 15 hardly in the entire year. So that is the type of activity."

Operations & Balance Sheet

Rajesh Aggarwal: "We don't take any write-offs in the market. So whatever is left at the end of the season, we pick that up from the channel. We don't leave the inventory with the channel at all because if I leave the inventory, and instead of 5 week on 10, and he is not going to pay to me."

Exports & CDMO


Guidance & Commitments

CommitmentSpecificsTimeline
Kaeros salesDouble total sales from ~₹110–₹111 cr baseFY27
Kaeros volume contributionReach 5% to 7%–8% of IIL's volumeFY27
IIL growthDouble-digit growth alongside Kaeros expansionFY27
Finance costReduce by at least 25%–30%FY27
Working capital cycleReduce to 120 days from 140–150 daysAchievable in FY27 if inventory liquidated
ICS plotsDouble the number from last year's ~₹30+ cr baseFY27
Premium product mix (Maharatna/Focused Maharatna)Move from 60%–63% to 60%–70%Next 3–4 years
Exports shareGrow to 10% of revenueNext 2–3 years
First discovery product filingFile in India upon receiving IUPAC nameExpected shortly; product launch in 2027
Sotanala formulation plantStart operationsAround Diwali (FY27)
Sotanala technical plant (first building)Start operationsMarch/April 2027
Dahej new building profitabilityTurn profitablePost-Diwali (FY27)
Nissan next product launchLaunch in early kharifNext year (FY28)

Key Metrics

MetricQ4 FY26
Revenue from operations₹2,140 cr (FY26), up ~7% YoY from ₹2,000 cr
Q4 revenue growth~19% YoY
Gross profit₹675 cr (FY26), up ~5% YoY from ₹641 cr
Gross profit margin31.5% (FY26), improved from 23.1% three years ago
EBITDA₹227 cr (FY26), up ~3% YoY from ₹221 cr
EBITDA margin10.6% (FY26), improved from 6.8% three years ago
PAT₹139 cr (FY26), slight decline from ₹142 cr; deferred tax increased by ~₹9 cr
ROE11.4% (FY26), improved from 6.9% three years ago
ROCE16.1% (FY26), improved from 10.4% three years ago
Q4 volume growth5% YoY
Q4 value growth14% YoY
Full-year volume growth5% YoY
Full-year value growth2% YoY
Revenue mix (FY26)B2C 73%, B2B 22%, exports 5%
Revenue from patented products₹322 cr (FY26), vs ~₹330 cr in FY25
Revenue from combination products₹324 cr (FY26), vs ₹311 cr in FY25
Revenue from in-licensing products₹226 cr (FY26), vs ₹229 cr in FY25
Revenue from 5 products launched in FY26₹40 cr
Revenue from products launched in FY25₹82 cr (FY26), up from ₹23 cr in FY25
Herbicide segment contribution39% of total sales (FY26)
Premium segment (Maharatna/Focused Maharatna) share~60–63% of B2C revenue
Exports share~5% of total revenue; target to reach 10% in 2–3 years
Kaeros revenue~₹110–111 cr (FY26), PAT above ₹5 cr
Finance cost (consolidated)₹16.87 cr (FY26), up from ₹6.86 cr in FY25
Capex guidance₹25–30 cr maintenance capex once FY27 projects complete
Farmers reached>75 lakh in FY26
ICS plots planned>70 for FY27
Field force headcount>700 sales headquarters, >1,000 brand-building staff, ~1,400 crop advisers at peak